News

Novartis has put a halt on its research and development venture in India, said Daniel Vasella, CEO of the company. This action is reportedly a result of the

Novartis has launched Prevacid24HR (lansoprazole delayed-release capsules 15mg/acid reducer) over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn. Prevacid24HR has received FDA approval in

Cequent Pharmaceuticals (Cequent) has filed an investigational new drug (IND) application with the FDA. CEQ508, an orally administered tkRNAi drug candidate, targets beta-catenin, a key oncogene implicated in

Immuno Solid-phase Allergy Chip, or ISAC, is a multi-array technology package designed to provide a detailed assessment of specific allergies as part of the initial patient assessment and

Diamyd Medical has completed patient recruitment in European Phase III study of the diabetes vaccine Diamyd. It is estimated that results from the study can be reported during

AkzoNobel is to enhance its portfolio of sustainable technologies after signing an agreement with the Dow Chemical Company (Dow) to acquire its powder coatings activities. Financial details were

Ionian Technologies and Roche Diagnostics have entered into a molecular diagnostic manufacturing agreement based on Ionian’s rapid isothermal nucleic acid amplification technology. Under this collaboration, Roche is expected

Trimurthi Drugs and Pharmaceuticals has announced that it has received NS-EN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from ‘kvalitet veritas quality assurance’,

FDA has acknowledged receipt of Sol-Gel Technologies’ (Sol-Gel) Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. The IND allows Sol-Gel to initiate